Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
1.
Sex Transm Dis ; 33(7): 458-63, 2006 Jul.
Article in English | MEDLINE | ID: mdl-16794548

ABSTRACT

OBJECTIVE: The objective of this study was to examine California clinicians' use of and attitudes toward patient-delivered partner therapy (PDPT) to treat sexual partners of patients infected with chlamydia. STUDY DESIGN: In 2002, a stratified random sample of primary care physicians and nurse practitioners completed a mailed, self-administered survey. Weighted frequencies were calculated to assess partner management practices, including PDPT, and attitudes toward PDPT. Multivariate models were constructed to determine independent predictors of PDPT use. RESULTS: Of 708 physicians and 895 nurse practitioners, approximately half (47% and 48%, respectively) reported that they use PDPT usually or always. Over 90% agreed that PDPT protects patients from reinfection and provides better care for patients with chlamydia. However, providers reported concerns that PDPT may result in incomplete care for the partner, may be dangerous without knowing the partner's medical or allergy history, is an activity the practice may not get paid for, and may get them sued. Obstetrics/gynecology and family practice physicians were more likely than internal medicine physicians to report routine use of PDPT. Concerns about adverse outcomes of PDPT were associated with less PDPT use. CONCLUSIONS: Although the proportion of California healthcare providers routinely using PDPT is comparatively high, further study is warranted to examine the circumstances under which this partner management strategy is used.


Subject(s)
Anti-Bacterial Agents/administration & dosage , Attitude of Health Personnel , Chlamydia Infections/prevention & control , Chlamydia trachomatis , Contact Tracing , Practice Patterns, Physicians'/statistics & numerical data , Sexual Partners , Adult , Aged , Aged, 80 and over , California , Chlamydia Infections/transmission , Female , Humans , Male , Middle Aged , Multivariate Analysis , Nurse Practitioners , Physicians , Surveys and Questionnaires
2.
Sex Transm Dis ; 33(2): 106-10, 2006 Feb.
Article in English | MEDLINE | ID: mdl-16432482

ABSTRACT

BACKGROUND AND OBJECTIVES: Currently, azithromycin is not considered a first-line treatment for Chlamydia trachomatis in pregnant women. We evaluated the use, efficacy, and safety of azithromycin compared with erythromycin and amoxicillin in the treatment of genital chlamydial infection during pregnancy. METHODS: This was a retrospective cohort study of pregnant women with genital chlamydial infection. Data on antibiotics prescribed, test-of-cure (TOC) results, and maternal and infant complications were collected from medical records. RESULTS: Of the 277 women in the study sample, 69% were initially prescribed azithromycin, 9% amoxicillin, and 19% erythromycin. Eight-one percent of subjects had a TOC 7 or more days after diagnosis and before delivery. Treatment efficacy, as defined by a negative TOC, was 97% (95% confidence interval [CI], 92.9-99.2) for azithromycin, 95% (95% CI, 76.2-99.9) for amoxicillin, and 64% (95% CI, 44.1-81.4) for erythromycin. The efficacy of azithromycin was significantly higher than erythromycin (P < 0.0001). There were no significant differences in efficacy by age, race/ethnicity, concurrent sexually transmitted disease diagnosis, partner treatment, or substance use. Furthermore, there was no difference in complications for women or infants exposed to azithromycin compared with those treated with other regimens. CONCLUSION: Clinical outcome data from this study population of women and infants support both efficacy and safety of azithromycin for treatment of C. trachomatis in pregnancy.


Subject(s)
Anti-Bacterial Agents/therapeutic use , Chlamydia Infections/drug therapy , Chlamydia trachomatis , Genital Diseases, Female/drug therapy , Pregnancy Complications, Infectious/drug therapy , Amoxicillin/therapeutic use , Azithromycin/therapeutic use , Chlamydia Infections/microbiology , Chlamydia trachomatis/drug effects , Cohort Studies , Erythromycin/therapeutic use , Female , Genital Diseases, Female/microbiology , Humans , Infant, Newborn , Pregnancy , Pregnancy Complications, Infectious/microbiology , Pregnancy Outcome , Retrospective Studies , Treatment Outcome
3.
J Gen Intern Med ; 20(12): 1102-7, 2005 Dec.
Article in English | MEDLINE | ID: mdl-16423098

ABSTRACT

BACKGROUND: Because sexually transmitted chlamydial infections are common among young women, it is critical that providers screen and manage these infections appropriately. OBJECTIVE: To assess the Chlamydia care practices of California primary care physicians and nurse practitioners. DESIGN: Cross-sectional, self-report mail survey. PARTICIPANTS: A stratified random sample of primary care physicians and a convenience sample of primary care nurse practitioners in California. MEASUREMENTS AND MAIN RESULTS: Survey content included 5 topic areas: sexual history taking, management of cervicitis, management of a nonpregnant Chlamydia-infected patient, availability of onsite STD services, and Chlamydia screening practices and attitudes. Main outcome measure was the reported frequency of Chlamydia screening of sexually active women age 25 and younger. Respondents included 708 physicians (49% response rate) and 895 nurse practitioners (63% response rate). Nearly half of physicians (47%, 95% confidence interval [CI], 42% to 51%) and a majority of nurse practitioners (79%, 95% CI, 77% to 82%) reported routine Chlamydia screening of women under age 20; similar proportions reported routinely screening women aged 20 to 25 years. Independent predictors of screening among physicians were adolescent medicine specialty, female gender, practicing in a nonprivate setting, and having a higher volume of female patients. Additional findings included the overscreening of women over age 25 by nurse practitioners and the shared concern among providers that Chlamydia screening may not be reimbursed. CONCLUSIONS: The Chlamydia care practices of many California primary care providers are inconsistent with current guidelines. Targeted provider education and improved reimbursements are potential strategies for improvement.


Subject(s)
Chlamydia Infections/diagnosis , Primary Health Care/methods , Professional Practice , Sexually Transmitted Diseases, Bacterial/diagnosis , Adolescent , Adult , California , Female , Humans , Male , Mass Screening , Middle Aged , Nurse Practitioners , Physicians, Family
SELECTION OF CITATIONS
SEARCH DETAIL
...